Peer support may boost HIV treatment success in people who inject drugs

NCT ID NCT03987282

Terminated Disease control Sponsor: Yale University Source: ClinicalTrials.gov ↗

First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time

Summary

This study tests whether adding peer-based counseling to standard HIV and opioid treatment helps people who inject drugs stay on their medications and achieve viral suppression. Participants receive either enhanced usual care or extra support from a peer counselor. The goal is to see if this approach improves treatment retention and reduces opioid use.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: peer-based counseling
What this could lead to: If successful, this approach could improve HIV treatment adherence and viral suppression rates among people who inject drugs, informing better care models in low-resource settings.
What could go wrong: This is a small, early-stage implementation study with only 2 participants, so results may not be generalizable. The intervention relies on self-reported adherence, which can be unreliable.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV SEROPOSITIVITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease HIV Seropositivity opiate dependence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV SEROPOSITIVITY OPIOID-USE DISORDER

Contacts and locations

Locations

Universiti Sains Malalysia

Tasek Gelugor, Pulau Pinang, 11800, Malaysia

More trials for these conditions

Other studies related to the condition(s) this trial covers.